CA-19-9 antigen

(redirected from Gastrointestinal cancer)
Also found in: Wikipedia.

CA-19-9 antigen

tumor antigen present in cholangiocarcinomas and pancreatic carcinomas.

CA-19-9 an·ti·gen

(an'ti-jen)
Tumor antigen present in cholangiocarcinomas and pancreatic carcinomas.
References in periodicals archive ?
Limburg's extensive research and clinical experience with gastrointestinal cancer makes him well suited to advise Exact Sciences where he will assess research opportunities to inform, expand and accelerate the adoption of effective colon cancer screening options such as Cologuard.
A study presented at the European Society for Medical Oncology World Congress on Gastrointestinal Cancer in June 2017 suggests that consuming a Mediterranean-style diet that includes more fish, more fruit, and fewer soft drinks is a dietary pattern that offers the most protection against colorectal cancer.
Background: As the clinical value of cytokeratin-19 (CK19) and thymidine kinase-1 (TK1) in advanced gastrointestinal cancer remains controversial, we investigated their expression and clinical significance in this disease.
Taking aspirin regularly reduced the risk of colorectal (bowel) cancer by 19 per cent and of gastrointestinal cancer by 15 per cent.
Professor Peter Naredi, scientific co-chair of the Congress, said: "Dr Frouws and colleagues show that in more than 13,000 patients who were diagnosed with a gastrointestinal cancer, aspirin improved survival compared with those who did not use it.

Full browser ?